Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ha seva b/phuket/3073/2013, divji tip, podoben sevu b/phuket/3073/2013; ha seva b/washington/02/2019, divji tip, podoben sevu b/washington/02/2019; ha seva a/victoria/2570/2019, ivr-215, podoben sevu a/victoria/2570/2019 (h1n1)p; ha seva ivr-224 (iz seva a/cambodia/e0826360/2020, podoben sevu a/cambodia/e0826 - suspenzija za injiciranje v napolnjeni injekcijski brizgi - ha seva b/phuket/3073/2013, divji tip, podoben sevu b/phuket/3073/2013 15 µg / 1 brizga  ha seva b/washington/02/2019, divji tip, podoben sevu b/washington/02/201915 µg / 1 brizga  ha seva a/victoria/2570/2019, ivr-215, podoben sevu a/victoria/2570/2019 (h1n1)p15 µg / 1 brizga  ha seva ivr-224 (iz seva a/cambodia/e0826360/2020, podoben sevu a/cambodia/e082615 µg / 1 brizga; ha seva b/washington/02/2019, divji tip, podoben sevu b/washington/02/2019 15 µg / 1 brizga  ha seva a/victoria/2570/2019, ivr-215, podoben sevu a/victoria/2570/2019 (h1n1)p15 µg / 1 brizga  ha seva ivr-224 (iz seva a/cambodia/e0826360/2020, podoben sevu a/cambodia/e082615 µg / 1 brizga; ha seva a/victoria/2570/2019, ivr-215, podoben sevu a/victoria/2570/2019 (h1n1)p 15 µg / 1 brizga  ha seva ivr-224 (iz seva a/cambodia/e0826360/2020, podoben sevu a/cambodia/e082615 µg / 1 brizga; ha seva ivr-224 (iz seva a/cambodia/e0826360/2020, podoben sevu a/cambodia/e0826 - cepivo proti gripi, z delci virusov ali s površinskimi antigeni, inaktivirano

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ha seva b/phuket/3073/2013, divji tip, podoben sevu b/phuket/3073/2013; ha seva b/washington/02/2019, divji tip, podoben sevu b/washington/02/2019; ha seva a/victoria/2570/2019, ivr-215, podoben sevu a/victoria/2570/2019 (h1n1)p; ha seva ivr-224 (iz seva a/cambodia/e0826360/2020, podoben sevu a/cambodia/e0826 - suspenzija za injiciranje v napolnjeni injekcijski brizgi - ha seva b/phuket/3073/2013, divji tip, podoben sevu b/phuket/3073/2013 15 µg / 1 brizga  ha seva b/washington/02/2019, divji tip, podoben sevu b/washington/02/201915 µg / 1 brizga  ha seva a/victoria/2570/2019, ivr-215, podoben sevu a/victoria/2570/2019 (h1n1)p15 µg / 1 brizga  ha seva ivr-224 (iz seva a/cambodia/e0826360/2020, podoben sevu a/cambodia/e082615 µg / 1 brizga; ha seva b/washington/02/2019, divji tip, podoben sevu b/washington/02/2019 15 µg / 1 brizga  ha seva a/victoria/2570/2019, ivr-215, podoben sevu a/victoria/2570/2019 (h1n1)p15 µg / 1 brizga  ha seva ivr-224 (iz seva a/cambodia/e0826360/2020, podoben sevu a/cambodia/e082615 µg / 1 brizga; ha seva a/victoria/2570/2019, ivr-215, podoben sevu a/victoria/2570/2019 (h1n1)p 15 µg / 1 brizga  ha seva ivr-224 (iz seva a/cambodia/e0826360/2020, podoben sevu a/cambodia/e082615 µg / 1 brizga; ha seva ivr-224 (iz seva a/cambodia/e0826360/2020, podoben sevu a/cambodia/e0826 - cepivo proti gripi, z delci virusov ali s površinskimi antigeni, inaktivirano

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

sanofi pasteur - ha seva b/phuket/3073/2013, divji tip, podoben sevu b/phuket/3073/2013; ha seva a/darwin/9/2021, ivr-228, podoben sevu a/darwin/9/2021 (h3n2); ha seva b/michigan/01/2021, divji tip, podoben sevu b/austria/1359417/2021; ha seva a/victoria/2897/2022, ivr-238, podoben sevu a/victoria/4897/2022 (h1n1)p - suspenzija za injiciranje - ha seva b/phuket/3073/2013, divji tip, podoben sevu b/phuket/3073/2013 15 µg / 1 brizga  ha seva a/darwin/9/2021, ivr-228, podoben sevu a/darwin/9/2021 (h3n2)15 µg / 1 brizga  ha seva b/michigan/01/2021, divji tip, podoben sevu b/austria/1359417/202115 µg / 1 brizga  ha seva a/victoria/2897/2022, ivr-238, podoben sevu a/victoria/4897/2022 (h1n1)p15 µg / 1 brizga; ha seva a/darwin/9/2021, ivr-228, podoben sevu a/darwin/9/2021 (h3n2) 15 µg / 1 brizga  ha seva b/michigan/01/2021, divji tip, podoben sevu b/austria/1359417/202115 µg / 1 brizga  ha seva a/victoria/2897/2022, ivr-238, podoben sevu a/victoria/4897/2022 (h1n1)p15 µg / 1 brizga; ha seva b/michigan/01/2021, divji tip, podoben sevu b/austria/1359417/2021 15 µg / 1 brizga  ha seva a/victoria/2897/2022, ivr-238, podoben sevu a/victoria/4897/2022 (h1n1)p15 µg / 1 brizga; ha seva a/victoria/2897/2022, ivr-238, podoben sevu a/victoria/4897/2022 (h1n1)p - cepivo proti gripi, z delci virusov ali s površinskimi antigeni, inaktivirano

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ha seva b/phuket/3073/2013, divji tip, podoben sevu b/phuket/3073/2013; ha seva a/darwin/9/2021, ivr-228, podoben sevu a/darwin/9/2021 (h3n2); ha seva b/michigan/01/2021, divji tip, podoben sevu b/austria/1359417/2021; ha seva a/victoria/2897/2022, ivr-238, podoben sevu a/victoria/4897/2022 (h1n1)p - suspenzija za injiciranje - ha seva b/phuket/3073/2013, divji tip, podoben sevu b/phuket/3073/2013 15 µg / 1 brizga  ha seva a/darwin/9/2021, ivr-228, podoben sevu a/darwin/9/2021 (h3n2)15 µg / 1 brizga  ha seva b/michigan/01/2021, divji tip, podoben sevu b/austria/1359417/202115 µg / 1 brizga  ha seva a/victoria/2897/2022, ivr-238, podoben sevu a/victoria/4897/2022 (h1n1)p15 µg / 1 brizga; ha seva a/darwin/9/2021, ivr-228, podoben sevu a/darwin/9/2021 (h3n2) 15 µg / 1 brizga  ha seva b/michigan/01/2021, divji tip, podoben sevu b/austria/1359417/202115 µg / 1 brizga  ha seva a/victoria/2897/2022, ivr-238, podoben sevu a/victoria/4897/2022 (h1n1)p15 µg / 1 brizga; ha seva b/michigan/01/2021, divji tip, podoben sevu b/austria/1359417/2021 15 µg / 1 brizga  ha seva a/victoria/2897/2022, ivr-238, podoben sevu a/victoria/4897/2022 (h1n1)p15 µg / 1 brizga; ha seva a/victoria/2897/2022, ivr-238, podoben sevu a/victoria/4897/2022 (h1n1)p - cepivo proti gripi, z delci virusov ali s površinskimi antigeni, inaktivirano

Evropska unija - slovenščina - EMA (European Medicines Agency)

hra pharma rare diseases - ketokonazol - cushingov sindrom - antimikotiki za sistemsko uporabo - ketokonazol hra je indiciran za zdravljenje endogenega cushingovega sindroma pri odraslih in mladostnikih, starejših od 12 let.

Evropska unija - slovenščina - EMA (European Medicines Agency)

recordati rare diseases - osilodrostat fosfat - cushingov sindrom - kortikosteroidi za sistemsko uporabo - isturisa je primerna za zdravljenje endogenih cushingov sindrom pri odraslih.

Evropska unija - slovenščina - EMA (European Medicines Agency)

otsuka novel products gmbh - delamanid - tuberkuloza, odporna proti multidrugom - antimikobakterij - deltyba is indicated for use as part of an appropriate combination regimen for pulmonary multi-drug resistant tuberculosis (mdr-tb) in adults, adolescents, children and infants with a body weight of at least 10 kg when an effective treatment regimen cannot otherwise be composed for reasons of resistance or tolerability (see sections 4. 2, 4. 4 in 5. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.

Evropska unija - slovenščina - EMA (European Medicines Agency)

recordati rare diseases - pasireotid - acromegaly; pituitary acth hypersecretion - hipofize in hipotalamični hormoni in analogi - zdravilo signifor je indicirano za zdravljenje odraslih bolnikov s cushingovo boleznijo, za katere operacija ni možna ali za katero operacija ni uspela. signifor je indiciran za zdravljenje odraslih bolnikov z acromegaly, za katere kirurgija ni opcija ali ni bil zdravljenja in ki so neustrezno nadzorovano na zdravljenje z drugim somatostatin analogni.

Evropska unija - slovenščina - EMA (European Medicines Agency)

intervet international bv - rezokortol butirat - kortikosteroidi, dermatološki preparati - psi - zdravljenje akutnega lokaliziranega vlažnega dermatitisa.

Evropska unija - slovenščina - EMA (European Medicines Agency)

ecuphar - hidrokortizon aceponat - kortikosteroidi, dermatološki preparati - psi - za simptomatsko zdravljenje vnetnih in pruritskih dermatoz pri psih. for alleviation of clinical signs associated with atopic dermatitis in dogs.